Probiotics to Prevent Pneumonia in Critically Ill Kids in the PICU
Official title: Assessment of Probiotic Role in Prevention of Ventilator Associated Pneumonia in Critically- Ill Children Admitted at Pediatric Intensive Care Unit
Run by Tanta University · NCT07848165 · Data updated 2026-11-12
We’re testing whether giving probiotics to critically ill children on a ventilator helps prevent ventilator-associated pneumonia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 1 Month to 18 Years |
| Sex | All |
| Enrollment | 68 (estimated) |
| Sponsor | Tanta University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Tanta, Al Gharbia) |
| Status | Recruiting |
| Started | July 1, 2026 |
| Main results expected | February 1, 2027 |
| Study ends | February 1, 2027 |
| Registry record updated | September 29, 2026 |
| Trial ID | NCT07848165 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are critically ill children aged 1 month to 18 years who are on mechanical ventilation and not ventilated for a chest infection.
✕Probably not a fit
Patients who do not respond to probiotic therapy or who have conditions that contraindicate enteral feeding may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional trial will assess whether probiotic supplementation, in addition to standard care, reduces the incidence of ventilator-associated pneumonia among children aged 1 month to 18 years who are critically ill and on mechanical ventilation in the pediatric intensive care unit at Tanta University Hospitals. The study will compare probiotic use with standard management to see if gut bacteria influence infection risk. Early- vs. late-onset VAP will be considered, with awareness of potential antibiotic-resistant pathogens in longer ICU stays. Exclusion criteria include recent enteral vaccines, significant immunosuppression, feeding contraindications, and certain gastrointestinal conditions.
Why it matters
Potential benefit: If successful, probiotics could lower the risk of VAP and shorten ventilation and ICU stay for some children.
How similar studies have gone: Previous studies in other populations suggest probiotics can reduce respiratory infections, but results in critically ill children are variable and further validation is needed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Critically ill children from 1 month to 18 years. * Both sexes. * Ventilated not due to chest infection. Exclusion Criteria: * Children recently received enteral vaccines. * Children receiving chronic immunosuppressive such as chemotherapy agents. and immunosuppressive medications, and high dose corticosteroids (more than 1 milligram per kilogram). * Children with contraindications of enteral feeding. * Children with gastrointestinal bleeding. * Children with open wounds following major surgery. * Children with short gut syndrome.
Where it's running
-
Tanta University
Tanta, Al Gharbia, Egypt Recruiting
Study contacts
- Study coordinator: Yomna G El-Feky, MD
- Email: Youmna.elfeky@med.tanta.edu.eg
- Phone: 00201005562005
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Barley and kefir to support gut health in active adults
This study tests whether a daily barley and kefir meal for four weeks can change gut microbiota in physically active adults and whether those changes relate to certain metabolites in blood and urine.
-
Probiotic Y7 cocktail to help with early Parkinson’s symptoms
A 12-week randomized trial will test whether a probiotic Y7 cocktail helps people with early Parkinson’s disease by possibly improving motor, thinking, and everyday symptoms.
-
B Lymphocyte Populations in the Lungs of ICU Patients on Ventilation
This study tests the presence and roles of B lymphocytes in the lungs of adults on invasive ventilation, to see how humoral immunity relates to ventilator-associated pneumonia.
-
Symprove probiotic for ongoing gut symptoms in coeliac disease
This will try the Symprove probiotic drink to see if it reduces ongoing gut symptoms in adults with coeliac disease who are already following a strict gluten‑free diet.
-
Comparing probiotic and ethyl lauroyl arginate mouthwashes for lowering cavity‑causing bacteria and plaque in Egyptian schoolchildren
This study will test whether a probiotic mouthwash or an ethyl lauroyl arginate mouthwash better lowers Streptococcus mutans, reduces dental plaque, and affects salivary pH in healthy Egyptian children aged 6–12.
-
Lactoferrin to help prevent infections in ventilated newborns
This study tests whether giving lactoferrin to ventilated neonates can help prevent ventilator-associated pneumonia and related complications.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.